Evidence map›Paper›PMID 31908396›Full record

Observational studyWorld journal of gastroenterology2019

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms.

Silvia Nardelli, Oliviero Riggio, Davide Rosati, Stefania Gioia, Alessio Farcomeni, Lorenzo Ridola

Abstract readObservational Study
In one paragraph

Observational study in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Silvia NardelliDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Oliviero RiggioDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Davide RosatiDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Stefania GioiaDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy.
Alessio FarcomeniDepartment of Economics & Finance, University of Rome "Tor Vergata", Rome 00185, Italy.
Lorenzo RidolaDepartment of Translational and Precision Medicine, "Sapienza" University of Rome, Rome 00185, Italy. lorenzo.ridola@uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlterations in health-related quality of life (HRQoL) and neuropsychological disorders were described in the hepatitis C virus (HCV) patients. Although several studies investigated the modifications of HRQoL after HCV eradication, no data exists on the modifications of neuropsychological symptoms.

aimTo investigate the effect of directly acting antivirals (DAAs) treatment on HRQoL and neuropsychological symptoms.

methodsThirty nine patients with HCV infection underwent a neuropsychological assessment, including Zung-Self Depression-Rating-Scale, Spielberg State-Trait Anxiety Inventory Y1-Y2 and the Toronto-Alexithymia Scale-20 items before and after DAAs treatment. HRQoL was detected by Short-Form-36 (SF-36).

resultsAll HRQoL domains, but role limitation physical and bodily pain, significantly improved after treatment. Interestingly, after DAAs treatment, all domains of HRQoL returned similar to those of controls. Each neuropsychological test significantly improved after HCV eradication. A significant correlation was observed among each psychological test and the summary components of SF-36. At multiple linear regression analysis including each psychological test as possible covariates, Zung-Self Depression Rating Scale (Zung-SDS) score was independently and significantly related to summary components of the SF-36 in the basal state and the difference between Zung-SDS score before and after treatment was the only variable significantly and independently related to the modification of HRQoL induced by the treatment.

conclusionNeuropsychological symptoms strongly influenced HRQoL in HCV patients and there was a significant improvement of neuropsychological tests and HRQoL after DAAs treatment.

Indexed as

Quality of LifeAgedAntiviral AgentsAnxietyBenzimidazolesDepressionFemaleFluorenesHepacivirusHepatitis CHumansMaleMiddle AgedPsychological TestsSelf ReportSeverity of Illness IndexAntiviral AgentsBenzimidazolesFluorenesledipasvir, sofosbuvir drug combinationSofosbuvirUridine MonophosphateAlexithymiaDepressionDirectly acting antiviralsHealth related quality of lifeHepatitis C virusState and trait anxiety

Identifiers

PMID31908396
PMCPMC6938730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.